ACAD Stock Ownership Activity
ACADIA PHARMACEUTICALS INC 13F holders
No value investing guru has made any change to the ACADIA PHARMACEUTICALS INC (ACAD) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying ACAD now?
According to the latest SEC filing(s) ACADIA PHARMACEUTICALS INC (ACAD) has not been purchased by any super investor.
To see more about who is investing in ACADIA PHARMACEUTICALS INC (ACAD), please go to the ACAD ownership page.
2022 Q2
(1 result)
Current price: $16.81
30.59%
Reported price*: $24.22
2022 Q1
(1 result)
Current price: $16.81
30.59%
Reported price*: $24.22
2015 Q1
(1 result)
Current price: $16.81
47.05%
Reported price*: $31.75
2014 Q4
(1 result)
Current price: $16.81
47.05%
Reported price*: $31.75
2014 Q3
(1 result)
Current price: $16.81
32.11%
Reported price*: $24.76
2014 Q2
(1 result)
Current price: $16.81
25.59%
Reported price*: $22.59
2014 Q1
(1 result)
Current price: $16.81
30.91%
Reported price*: $24.33
2013 Q4
(1 result)
Current price: $16.81
32.73%
Reported price*: $24.99
8 of 8
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.